Your session is about to expire
← Back to Search
Sleep Management for Childhood Obesity
N/A
Recruiting
Led By Andrea B Goldschmidt, Ph.D.
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Must not have
Taking medication known to affect sleep/appetite (e.g., antihistamines, stimulants)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will assess the effects of an experimental sleep manipulation on eating-related self-regulation and its neural substrates, and on real-world eating behavior, among children with overweight/obesity.
Who is the study for?
This trial is for children who are overweight or obese and willing to have an MRI scan. It's not suitable for those with conditions affecting brain function, like a recent concussion, more than 10 hours of sleep per night, past eating disorders, sleep or psychiatric conditions, or if they're on medications that affect sleep or appetite.
What is being tested?
Project REST aims to see how changing the amount of sleep can influence children's self-control around eating and their brain activity related to food. The study will test whether more or less sleep affects real-world eating behavior in kids with weight issues.
What are the potential side effects?
Since this trial involves changes in sleeping patterns rather than medication, side effects may include tiredness from lack of sleep during the restriction phase and potential difficulty adjusting to new sleeping schedules.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am taking medication that can affect my sleep or appetite.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Eating Behavior
Change in Weight Status
Self-Regulatory Control
Secondary study objectives
Sleep Patterns
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Sleep restriction followed by extensionExperimental Treatment2 Interventions
Children will spend 8 hours in bed for one week, engage in one week of wash-out, and then spend 11 hours in bed for one week.
Group II: Sleep extension followed by restrictionExperimental Treatment2 Interventions
Children will spend 11 hours in bed for one week, engage in one week of wash-out, and then spend 8 hours in bed for one week.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sleep extension
2019
N/A
~220
Sleep restriction
2005
Completed Phase 1
~450
Find a Location
Who is running the clinical trial?
University of PittsburghLead Sponsor
1,792 Previous Clinical Trials
16,359,866 Total Patients Enrolled
The Miriam HospitalLead Sponsor
245 Previous Clinical Trials
37,778 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,943 Previous Clinical Trials
47,797,779 Total Patients Enrolled
Andrea B Goldschmidt, Ph.D.Principal InvestigatorUniversity of Pittsburgh
2 Previous Clinical Trials
119 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am overweight or obese.I am taking medication that can affect my sleep or appetite.You sleep more than 10 hours per night on average.I am overweight or obese.I am willing to have a 30-minute MRI scan.I have been diagnosed with an eating, sleep, or psychiatric disorder.I am currently being treated for sleep issues or weight management.I have had a recent brain injury affecting my thinking or decision-making.
Research Study Groups:
This trial has the following groups:- Group 1: Sleep restriction followed by extension
- Group 2: Sleep extension followed by restriction
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.